Puma Biotechnology logo
Puma Biotechnology PBYI
$ 2.97 2.41%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Puma Biotechnology Financial Ratios 2011-2024 | PBYI

Annual Financial Ratios Puma Biotechnology

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

13.6 87115.3 -4.2 -6.8 -4.2 -9.0 -8.4 -3.7 -5.6 -44.6 -65.2 -7.1 -

P/S

1.2 0.8 0.5 1.8 1.2 4.1 88.3 - - - - - -

EPS

0.5 - -0.7 -1.5 -75595 -3.0 -7.8 -8.3 -7.5 -4.7 -1.9 -3.4 -1.3

EV (Enterprise Value)

385 M 298 M 289 M 571 M 471 M 1.14 B 2.47 B 869 M 1.34 B 6.34 B 3.54 B 412 M -52.4 M

EBITDA per Share

0.94 0.75 0.31 -0.51 -0.77 -2.3 -7.79 -8.27 -7.46 -4.72 -1.9 -3.41 -

EV/EBITDA

24.2 -23.4 -11.7 -12.2 -8.3 -3.0 -5.5 -44.4 -64.7 -5.3 -

PEG

-0.72 -2297.34 0.06 0.2 -0.12 -0.15 -1.58 0.33 0.1 0.3 -1.47 0.04 -

P/B

5.5 8.1 -50.5 -68.2 18.0 29.9 45.9 4.9 6.5 54.1 42.5 4.1 -

P/CF

10.8 -11.0 6.0 525.3 14.2 -41.5 -11.0 -6.9 -8.6 -80.7 -64.0 -11.7 -

ROE %

40.40 0.01 1190.76 1008.15 -432.89 -331.06 -547.74 -131.54 -116.15 -121.29 -65.08 -57.68 -

ROA %

9.37 0.00 -12.85 -24.57 -32.18 -43.83 -176.38 -109.19 -99.77 -87.22 -52.37 -49.01 -

ROCE %

61.08 109.77 -52.74 510.87 -26.32 -49.31 -272.79 -128.45 -115.85 -120.25 -64.43 -57.27 -

Current Ratio

1.3 1.1 1.0 1.0 1.8 3.0 1.8 6.3 6.9 3.4 5.0 6.9 -

DSO

68.3 58.3 41.9 44.1 38.7 31.9 127.5 - - - - - -

DIO

33.8 38.5 30.3 30.7 31.4 27.7 132.9 - - - - - -

DPO

38.8 58.3 66.6 144.9 190.2 218.1 1814.0 - - - - - -

Operating Cycle

102.1 96.9 72.1 74.8 70.2 59.6 260.4 - - - - - -

Cash Conversion Cycle

63.3 38.5 5.5 -70.0 -120.0 -158.5 -1553.6 - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Puma Biotechnology

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.41 -0.09 -0.1 - 0.12 0.05 0.03 - -0.01 0.21 -0.08 - -1.09 -0.13 0.41 -0.38 -0.79 0.09 -0.43 -0.29 -0.44 -0.97 -0.26 -0.8 -0.37 -1.17 -0.65 -1.71 -2.07 -2.1 -1.97 -2.04 -2.02 -2.05 -2.19 -1.9 -1.87 -2.01 -1.66 -1.57 -1.19 -1.29 -0.67 -0.55 -0.5 -0.44 -0.41 -0.83 -1.29 -0.74 -0.59 - -0.09 -0.009 -0.001

EBITDA per Share

0.45 -0.04 0.01 - 0.18 0.11 0.16 - 0.06 0.27 0.04 - -0.02 -0.41 0.57 - -0.13 0.29 -0.31 - -0.21 -0.56 0.31 - -0.16 -1.01 -0.58 - -2.04 -2.1 -1.97 - -2.01 -2.03 -2.19 - -1.86 -2.01 -1.66 - -1.18 -1.28 -0.67 - -0.49 -0.44 -0.41 - -1.29 -0.73 -0.59 - -0.08 -0.01 -

ROE %

24.76 11.14 27.47 27.37 25.75 9.16 49.65 -1.78 407.23 817.87 753.06 492.24 744.19 863.89 824.16 1008.15 692.06 66.67 -90.58 -432.89 -458.23 -402.93 -317.86 -331.06 -361.81 -465.21 -482.00 -547.74 -462.15 -348.70 -234.42 -131.54 -126.87 -124.85 -124.52 -116.15 -126.76 -128.06 -129.84 -121.29 -99.71 -134.16 -166.06 -214.23 -212.24 -204.84 -197.43 -190.03 -191.85 -153.00 -114.14 -56.46 -18.82 -18.82 -18.82

ROA %

7.59 1.24 4.51 4.62 4.44 1.41 -1.34 -3.57 -23.31 -41.18 -43.14 -15.32 -21.45 -14.60 -11.24 -24.57 -23.19 -17.50 -34.82 -32.18 -39.26 -37.55 -38.73 -43.83 -70.70 -111.84 -141.76 -176.38 -166.41 -145.81 -125.13 -109.19 -106.18 -105.34 -105.97 -99.77 -103.21 -100.04 -96.93 -87.22 -73.33 -103.67 -132.18 -172.38 -171.55 -168.19 -164.84 -161.48 -165.51 -134.97 -104.43 -55.41 -18.47 -18.47 -18.47

ROCE %

44.22 35.32 55.90 55.14 65.94 54.58 99.58 61.44 143.42 214.60 97.07 148.10 351.95 473.82 410.47 323.53 240.79 -45.79 -73.62 -173.97 -206.85 -157.00 -130.18 -221.88 -367.17 -479.57 -505.44 -429.30 -460.75 -346.92 -231.93 -97.09 -126.57 -124.60 -124.43 -86.52 -117.25 -118.49 -120.21 -80.89 -97.96 -84.30 -66.19 -46.25 -66.32 -69.33 -65.66 -40.73 -41.34 -21.89 -10.49 -0.68 -0.61 -0.06 -0.01

Current Ratio

1.5 1.3 1.3 1.3 1.2 1.2 1.1 1.1 1.1 - 1.0 1.0 0.9 1.1 1.1 1.0 1.0 1.0 1.0 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.1 1.5 1.5 1.5 1.5 5.9 5.9 5.9 5.9 7.1 7.1 7.1 7.1 3.6 3.6 3.6 3.6 5.1 5.1 5.1 5.1 6.7 6.7 6.7 6.7 54.0 54.0 54.0 54.0

DSO

46.9 51.1 75.5 - 49.0 52.2 61.8 - 22.4 20.7 59.4 - 53.6 48.5 24.0 44.4 45.9 33.0 48.5 41.9 46.8 48.9 22.9 26.7 30.3 37.3 20.9 40.8 145.2 - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

18.4 69.1 60.3 - 45.7 44.3 29.1 - 19.9 22.3 60.5 - 65.8 - 17.3 - 31.7 - - - - 31.1 33.1 - 26.5 27.1 33.3 - 121.3 - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

32.9 96.2 67.4 - 44.1 63.0 51.9 - 54.5 22.7 78.2 - 138.5 - 35.1 - 110.8 - - - - 187.9 227.8 - 208.6 213.7 345.8 - 1655.9 - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

65.2 120.2 135.8 - 94.7 96.6 90.9 - 42.3 43.0 120.0 - 119.4 48.5 41.3 44.4 77.6 33.0 48.5 41.9 46.8 80.0 56.0 26.7 56.7 64.5 54.1 40.8 266.5 - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

32.3 24.0 68.4 - 50.6 33.5 39.0 - -12.2 20.3 41.8 - -19.1 48.5 6.2 44.4 -33.2 33.0 48.5 41.9 46.8 -107.9 -171.8 26.7 -151.9 -149.3 -291.6 40.8 -1389.4 - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency